Provenienza dei contatti di primo grado di Xiao Dong Cheng
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Pacific Securities Co. Ltd. (Broker)
15
| Operating Division | Investment Banks/Brokers | 15 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Xiao Dong Cheng tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
CSC Financial Co., Ltd. (Broker) | Investment Banks/Brokers | Analyst-Equity | |
Peking University
Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Graduate Degree | |
BOC International (China) Ltd. (Broker)
BOC International (China) Ltd. (Broker) Investment Banks/BrokersFinance BOC International (China) Ltd. (Broker) (BOC Broker) is the brokerage division of BOC International (China) Ltd. The firm is headquartered in Shanghai and was founded in 2002. BOC Broker provides brokerage services to their clients. | Investment Banks/Brokers | Analyst-Equity | |
THE PACIFIC SECURITIES CO., LTD | Investment Banks/Brokers | Chief Executive Officer | |
Pacific Securities Co. Ltd. /Asset Management/
Pacific Securities Co. Ltd. /Asset Management/ Investment ManagersFinance Part of Pacific Securities Co., Ltd., the Asset Management company is based in Yunnan, China. The Chinese company provides investment advice. The company was founded in 2004. The CEO is Chang Wei Li. | Investment Managers | Chief Executive Officer | |
Beijing Gigaceuticals Tech Co., Ltd.
Beijing Gigaceuticals Tech Co., Ltd. Internet Software/ServicesTechnology Services Beijing Gigaceuticals Tech Co., Ltd. is a company based in Beijing, China that is devoted to discovering new drugs using artificial intelligence. The Chinese company employ independently developed algorithms to analyze characteristics of different compounds and verify their predictions using biomedical experiments, thus providing candidate drugs for clinical trials. The company was founded in 2018 by Zheng Wei Xie and Qian Qian Liu, with Zheng Wei Xie serving as the CEO since 2018. | Internet Software/Services | Founder |
Statistiche
Distribuzione geografica
Cina | 7 |
Settori
Finance | 5 |
Consumer Services | 2 |
Technology Services | 2 |
Posizioni
Analyst-Equity | 16 |
Chief Executive Officer | 3 |
Graduate Degree | 1 |
Director of Research - Equity | 1 |
Founder | 1 |
Contatti più connessi
Insiders | |
---|---|
Tao Wei | 4 |
Chang Wei Li | 3 |
Qian Qian Liu | 2 |
Yu Zhou | 1 |
Shuang Ni | 1 |
Hua Zhu | 1 |
Li Jin Sun | 1 |
Peng Bo Sun | 1 |
Xiao Jun Ji | 1 |
Ai Min Li | 1 |
Jiong Zhou | 1 |
Yu Wang | 1 |
Xue Qian Wang | 1 |
Xue Zhang | 1 |
Zhi Feng Cheng | 1 |
- Borsa valori
- Insiders
- Xiao Dong Cheng
- Connessioni Società